Navigation Links
Cambrex Zenara Manufacturing Facility Receives European GMP Approval
Date:1/18/2011

EAST RUTHERFORD, N.J. and HYDERABAD, India, Jan. 18, 2011 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced today that the Danish Medicines Agency (DKMA) has issued a Certificate of Good Manufacturing Practice (GMP) compliance for its manufacturing site in Hyderabad, India, following an audit conducted in October 2010. The DKMA Certificate is accepted by all EU Health Authorities and by authorities of several other countries that recognize EU Certification.  

Ashok Narasimhan, President of Cambrex Zenara, commented, "We are very pleased with the results of the DKMA inspection. This commercially important and significant milestone for Cambrex confirms our commitment to quality in every aspect of operations management and reflects our efforts to sustain and continuously improve quality platforms."

The DKMA certification allows Cambrex to expedite the European rollout of Nicotine Replacement Therapy (NRT) products (chewing gums, lozenges and mini-lozenges), in addition to offering finished dosage forms of other pharmaceutical products to our European customers through an integrated value chain.

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.  


'/>"/>
SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Shawn P. Cavanagh Appointed Chief Operating Officer of Cambrex
2. Cambrex Zenara Supplies Product for Launch of Nicorette® in India
3. Cambrex Acquires Stake in Zenara Pharma
4. Cambrex to Announce Third Quarter 2010 Financial Results on November 3, 2010
5. Cambrex Acquires IEP GmbH
6. Cambrex Reports Third Quarter 2009 Results
7. Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
8. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
9. Kensey Nash Announces a Manufacturing Agreement with and Minority Investment in Orteq Sports Medicine
10. Gelikos OU Kosher Gelatin Gains Momentum in the Food Manufacturing Marketplace
11. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, Ltd. ... Patent and Trademark Office (USPTO) has issued a ... dendritic cell-based immunotherapeutic vaccine targeting six tumor antigens ... of US Patent No. 8,871,211, which issued October ... by administering a dendritic cell composition comprising peptide ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind ... Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ ... zu besuchen. Diese Tagung soll ... die Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, ...
(Date:12/15/2014)... -- BerGenBio AS, a biopharmaceutical company focused ... today announces that it has raised NOK90 million (c. ... existing investors. BerGenBio will use the proceeds ... pipeline of innovative cancer therapeutics, in particular an enlarged ... a first-in-class selective Axl kinase inhibitor, which is currently ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2BerGenBio Completes NOK90 Million Fundraising 2
... Anaphore Inc. today announced that the company ... Corporation (Osaka, Japan) for the research, development and commercialization ... The partnership will be based on ... called Atrimers(TM ) with binding domains that can ...
... MISSISSAUGA, Ontario, Dec. 13, 2010 Valeant Pharmaceuticals International, ... announced that Robert A. Ingram, Valeant,s lead independent director, ... replacing William M. Wells, who has resigned from the ... About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is ...
Cached Medicine Technology:Anaphore Enters R&D Partnership with Mitsubishi Tanabe Pharma to Develop and Commercialize Novel Protein Pharmaceuticals for Autoimmune Disorders 2Anaphore Enters R&D Partnership with Mitsubishi Tanabe Pharma to Develop and Commercialize Novel Protein Pharmaceuticals for Autoimmune Disorders 3
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... diseases, one worrisome phenomenon is when an illness that originated ... known as zoonosis -- is not uncommon and keeps researchers ... animal-borne disease might make inroads into the human population. ... and the culprits in this case were guinea pigs. More ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... health, but a growing body of evidence shows the ancient ... In fact, the benefits were similar to those of ... Chu, a doctoral candidate at Harvard University,s Health Policy Program ... that people randomly assigned to take yoga classes saw improvements ...
(Date:12/15/2014)... 15, 2014 Main Street Dental Team ... weighing in on a new study providing evidence on ... oral hygiene of children. , Sufficient enough evidence already ... as pop or juice drinks, with the onset of ... is whether drinks listed as 100% fruit juice, meaning ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... new study should reassure the millions of American women who ... breast cancer. "There is no association between migraine and ... professor of medicine at Harvard Medical School. "There is no ... there is no protective effect either." About 18 percent ...
(Date:12/15/2014)... OR (PRWEB) December 15, 2014 ... seeks to bring attention to restrictive state laws ... position paper on this important area of public ... Laws Can Compromise the Integrity of Independent Review, ... and access of independent peer review determinations can ...
Breaking Medicine News(10 mins):Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... , THURSDAY, Jan. 20 (HealthDay News) -- Emotions can ... products such as airbags, vaccines and smoke detectors, researchers ... they learn that a safety product may carry certain ... airbags sometimes injure or kill. But just because these ...
... HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay News) -- ... the help of aides Wednesday, bodes well for her ... will be moved Friday, just 13 days after a ... University Medical Center in Tucson indicate that the Arizona ...
... paper published Jan. 21 in the journal Science , ... Blossom Damania, PhD, has shown for the first time that ... a key molecule involved in the human immune response. ... Kenan, Jr. Distinguished Professor, Jenny Ting, PhD. First ...
... support system in the first year after diagnosis are less ... to new research from Vanderbilt-Ingram Cancer Center (VICC) and the ... author Meira Epplein, Ph.D., assistant professor of Medicine at VICC, ... of Clinical Oncology. Patients in the study ...
... have found that when patients and providers speak ... better health care quality. The findings were based ... Johnson Foundation,s Latino Health Survey. Understanding the ... important public health implications for providing services in ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, ... be behaving very differently depending on what side of ... example, H1N1 ("swine") flu still predominated in Britain, where 112 ... flu patients, and some doctors report running out of vaccine, ...
Cached Medicine News:Health News:Emotions May Sidetrack Use of Safety Devices 2Health News:Rep. Giffords Standing Up, Set to Begin Rehab Friday 2Health News:Rep. Giffords Standing Up, Set to Begin Rehab Friday 3Health News:Viral protein mimic keeps immune system quiet 2Health News:Strong social ties benefit breast cancer patients 2Health News:Speaking the same language means better health care quality, Wayne State University study finds 2Health News:H1N1 Flu Is Raging in Britain; Could U.S. Be Next? 2Health News:H1N1 Flu Is Raging in Britain; Could U.S. Be Next? 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: